Combined therapy of transarterial chemoembolization and stereotactic body radiation therapy versus transarterial chemoembolization for ≤5cm hepatocellular carcinoma: Propensity score matching analysis.

Combined therapy of transarterial chemoembolization and stereotactic body radiation therapy versus transarterial chemoembolization for ≤5cm hepatocellular carcinoma: Propensity score matching analysis.

Patients with liver cirrhosis and hepatocellular carcinoma (HCC) are often ineligible for resection or local ablation therapy due to poor liver function and/or difficult location. The aim of this study is to evaluate therapeutic outcomes of stereotactic body radiotherapy (SBRT) combined with transar...

Full description

Bibliographic Details
Main Authors: Baek Gyu Jun, Sang Gyune Kim, Young Don Kim, Gab Jin Cheon, Koon Hee Han, Jeong-Ju Yoo, Young Seok Kim, Soung Won Jeong, Jae Young Jang, Sae Hwan Lee, Suyeon Park, Hong Soo Kim
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2018-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC6209230?pdf=render

Internet

http://europepmc.org/articles/PMC6209230?pdf=render

Similar Items